Education
- 2007 – 2012: Residency Program in Obstetrics and Gynecology – 70/70 cum laude – Universit脿 degli Studi of Milan
- 2011: Visiting Research Fellow at The University of Texas MD Anderson Cancer Center – Gynecologic Oncology and Reproductive Medicine Department – Houston (TX), USA
- 2006: Medical Doctor – 110/110 cum laude – Universit脿 degli Studi of Milan (Italy)
- 2005: SOCRATES/ERASMUS Project – Universidad Aut贸noma de Madrid – Facultad de Medicina y Cirug铆a
Academic Appointments
- Current: Assistant Professor of Gynecology and Obstetrics (tenure track 鈥� RTT)
- 2020: National Scientific Qualification for Associate and Full Professorship in Gynecology and Obstetrics – Ministry of Education, University and Research, Italy
- 2016 – 2018: European Society of Gynaecological Oncology (ESGO) Training Fellowship at Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan; ESGO certification as an accredited European Gynaecological Oncologist
- 2017: Faculty at university specialization course 鈥淟infologia Clinica鈥� – Universit脿 degli Studi di Milano
- 2012 – 2013: Research Assignment: 鈥淧redittori Biologici di Risposta alla Chemioterapia nel Ca della Cervice Uterina鈥� – Gynecologic Oncology Dept – Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan
Membership and Affiliations
- 2024 – present: Expert Component – Internal Review Board (IRB), Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan
- 2022 – present: Member of EURACAN – European Reference Networks (ERN) for Rare and Low Prevalence Complex Diseases
- 2021 – present: Expert Evaluator EX2021D431400 – European Commission Funding & Tenders
- 2021 – present: Expert in Medical Devices – European Commission Directorate-General for Health and Food Safety
- 2021 – 2023: National Representative (NATREP) of Italy – European Network of Young Gynaecologic Oncologists (ENYGO)
- 2020 – present: Member of European Society of Gynaecological Oncology (ESGO)
- 2018 – present: Associate Editor and Topic Editor, Frontiers in Oncology 鈥� Women鈥檚 Cancer/Gynecological Oncology
- 2017 – present: Rater – McMaster Online Rating of Evidence (MORE), McMaster University, Canada
- 2015 – present: Board Member – Societ脿 Italiana di Oncologia Ginecologica (SIOG)
- 2011 – present: Member – AAGL鈥檚 Oncology Special Interest Group
- Editorial Board Member – Experimental and Therapeutic Medicine
- Editorial Board Member – International Journal of Gynecological Cancer
Awards
- 2021: International Journal of Gynecological Cancer (IJGC) Top Editorial Board Member Award
- 2020: International Journal of Gynecological Cancer (IJGC) Top Reviewer Award
- 2019: Publons Top Peer Reviewer – Clinical Medicine
- 2019: Publons Top Peer Reviewer – Cross Fields
- 2018: Publons Peer Review Award
- 2007: Lega Italiana per la Lotta contro i Tumori – Mantova, borsa di studio
Other
- Principal Investigator at INT-Milan: 鈥淧atient Outcomes following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer: a GO SOAR led Study (GO SOAR2)鈥� 鈥� Coordinating Center NHS Grampian, UK 鈥� protocol INT 11-23
- Principal Investigator at INT-Milan: 鈥淒etermining Post-Operative Morbidity & Mortality Following Gynaecological Oncology Surgery: a Multicentre, International, Prospective Cohort Study鈥� 鈥� GO SOAR 鈥� protocol INT 46-21
- Principal Investigator at INT-Milan: 鈥淐ytoreductive Surgery in Advanced Endometrial Cancer. Multicenter Retrospective Study鈥� 鈥� Coordinating Center Istituto Nazionale Tumori Napoli 鈥� protocol INT 95-20
- Principal Investigator and Study Coordinator: 鈥淭he role of micrometastasis and isolated tumor cells (ITCs) in uterine cancers submitted to sentinel lymph nodes procedure鈥� 鈥� Fondazione IRCCS Istituto Nazionale Tumori 鈥� Milano 鈥� Protocol INT 135-19v2.0 鈥� NCT04403867
- Principal Investigator: 鈥淩adical Abdominal Hysterectomy vs Laparoscopic Radical Hysterectomy in cervical cancer stage IA1-IB1鈥� 鈥� Coordinating Center Instituto Nacional de Cancerolog铆a (INC), Colombia 鈥� protocol INT 61-19
Dr Martinelli is a Gynecologist with special interest in Gynecologic Oncology. He is an expert in surgical techniques and innovative approaches, he actively participated in the introduction of sentinel nodes procedure in endometrial cancer. He had a 20 year career experience in cancer centers such us Fondazione IRCCS Istituto Nazionale dei Tumori of Milan, MD Anderson Cancer Center 鈥� Huston (TX) 鈥� USA. During his training he was awarded the certification of European Gynecologic Oncologist form the European Society of Gynaecological Oncology (ESGO).
In his early research career, he focused on cervical cancer studies, concentrating on nerve anatomy preservation. He then specialized in sentinel node mapping in gynecologic oncology. He is now considered an expert acting as external reviewer for the European guidelines on gynecologic cancer management. He is member of major national and international gynecologic oncology society as well as editorial board member of the official journal (International Journal of Gynecological Cancer) of the two main gyn-onc societies (IGCS and ESGO) and he is committed in teaching and spreading knowledge all over the world with tough connections with LATAM and US. Furthermore, he is an European Commission expert in medical devices and and expert evaluator of EU projects in medicine and AI.
In May 2024, Dr Martinelli joined 暗网禁区 University as Assistant Professor (RTT) of Gynecologic and Obstetrics and Director of the Gynecologic Oncology Surgical division at 暗网禁区 San Pio X.
Main research fields:
- Sentinel node mapping in gynecologic oncology
- Innovations in surgical techniques and devices
- Cytoreductive surgery
- Oncofertility
- Social media in gynecologic oncology
- Fotopoulou C, Eriksson AG, Planchamp F, Morice P, Taylor A, Sturdza A, Florin Coza O, Halaska MJ, Martinelli F, Armbrust R, Chargari C. . Int J Gynecol Cancer. 2024 Feb 23:ijgc-2024-005293. doi: 10.1136/ijgc-2024-005293. Epub ahead of print. PMID: 38395448
- NIHR Global Health Unit on Global Surgery; COVIDSurg Collaborative. . [Martinelli F. Local collabolator]. . Lancet. 2022 Nov 5;400(10363):1607-1617. doi: 10.1016/S0140-6736(22)01846-3. Epub 2022 Oct 31.PMID: 36328042 PMC9621702
- Martinelli F, Ditto A, Filippi F, Vinti D, Bogani G, Leone Roberti Maggiore U, Evangelista M, Signorelli M, Chiappa V, Lopez S, Somigliana E, Raspagliesi F. . Int J Gynecol Cancer. 2021 Mar;31(3):457-461. doi: 10.1136/ijgc-2020-001740. PMID: 33649014
- Martinelli F, Garbi A. . Int J Gynecol Cancer. 2020 Aug;30(8):1101-1107. doi: 10.1136/ijgc-2020-001585. Epub 2020 Jun 7. PMID: 32513664; PMCID: PMC7299657
- Martinelli F, Ditto A, Signorelli M, Bogani G, Chiappa V, Lorusso D, Scaffa C, Recalcati D, Perotto S, Haeusler E, Raspagliesi F. . Gynecol Oncol. 2017 Sep;146(3):525-530. doi: 10.1016/j.ygyno.2017.06.014. Epub 2017 Jul 5. PMID: 28625394.